IP Library › Granted Patent US 11,254,716
Granted Patent B2
US 11,254,716 · App. 16/339,139 · Granted Feb 22, 2022

Peptides for binding epidermal growth factor

Inventors: Minghua Dai (Plymouth, MN); Amy K. McNulty (Stillwater, MN); Federica Sgolastra (St. Paul, MN); Jie Liu (Woodbury, MN); Jana Ninkovic (St. Paul, MN); Robert T. Fitzsimons, Jr. (Minneapolis, MN)
Assignee: 3M Innovative Properties Company
C07K14/435C12N15/85A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,254,716
App. No.
16/339,139
Granted
Feb 22, 2022
Kind
B2
Abstract

A polypeptide having a sequence at least 60% identical to SEQ ID NO: 1 (WFEWPYWEMNVPDVWN) is provided. The polypeptide includes no more than 100 total amino acid residues.

Claims (2)

1. A polypeptide of SEQ ID NO: 1, 2, 3, or 4.

2. A DNA encoding the polypeptide of claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2019
From: DAI, MINGHUA; MCNULTY, AMY K.; SGOLASTRA, FEDERICA; LIU, JIE; NINKOVIC, JANA; FITZSIMONS, ROBERT T., JR.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 048781/0762 →